&w=3840&q=100)
Sensex, Nifty trade flat as tariff updates keep D-street mood in check
At 11:50 am, BSE Sensex was down by a mere 78 points, trading at 83,355.91 level. Whereas, NSE Nifty was trading below the psychological 25,500 level, down by just 21 points.
D-Street's fear gauge, Nifty VIX, surged by over 2 per cent as tariff-related uncertainties dominated market sentiment. Sectorally, Nifty FMCG was among the top-performing indices after several big players in the industry released their quarterly updates. Nifty PSU Bank was just marginally up by 0.19 per cent, trading at 7,166.
However, major sectors were trading in red, with Nifty Media being the worst performer, down by 1.31 per cent.
From the Sensex pack, Hindustan Unilever (HUL), NTPC, Asian Paints and Reliance were among the top gainers. On the flip side, Tech Mahindra, Bharat Electronics, Eternal (Zomato), UltraTech Cement and Maruti Suzuki were the top laggards.
Broader markets also stayed volatile. The Nifty Midcap 100 was trading at 59,581, down by 0.16 per cent. The pain was deeper in the Nifty Smallcap 100, which slipped 0.48 per cent to 18,942.
Consumer stocks shine
Shares of major FMCG players, including Dabur and Godrej Consumer Products, witnessed a sharp rise of as much as 5 per cent on the bourses as investor mood turned euphoric after healthy quarterly updates. For instance, Dabur is expecting strong performance in its healthcare, home and personal care segment. However, the beverage portfolio might see some pain due to uneven monsoons.
Hindustan Unilever shares experienced similar momentum and were among the top gainers from the Sensex pack.
The Nifty FMCG index, which has struggled to trade in green territory so far this year, was trading at 55,500 level, experiencing an increase of 1.4 per cent. In contrast, the benchmark Nifty index was trading flat.
Momentum in check
The ongoing geopolitical events will keep markets consolidated in the near-term, as per analysts. But the earnings season might bring out some movement if Q1 delivers some surprises.
"The short-term issues are unlikely to have any long-term impact on the market. Short-term dips can be used by long-term investors to buy high quality stocks, preferably in fairly valued largecaps," said VK Vijayakumar, chief investment strategist at Geojit Investments.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
an hour ago
- Mint
Shares to buy or sell: Sachin Gupta of 5paisa recommends Balrampur Chini, Metropolis Healthcare shares today
Stock market today: Indian stock markets opened with some pressure on Tuesday as worries regarding US President Donald Trump's new tariff measures came to the forefront. However, investors seemed to adopt a cautious "wait and watch" stance, looking for more clarity on the situation. Currently, the domestic benchmark indices are trading flat. The Nifty 50 index started at 25,427.85, down 33.45 points or 0.13%, while the Sensex experienced a slight dip, opening at 83,387.03, down by 55.47 points or 0.07%. Experts noted that the market's reaction was mild and not panicked, unlike the period from April 2nd to April 9th. In the last 90 days, the markets have shown increased resilience, moving past the uncertainties surrounding Trump's policies to focus on his actions. On the technical front, Sachin Gupta of 5paisa believes Nifty 50's near term support and resistance to be at 25,180/25,000 and 25,600/25,740. Gupta recommends two stocks to buy in the near-term. Here's what he says about the overall market. The Nifty 50 index ended the session nearly flat to close at 25,461.3, as the market struggled to find direction. The overall market sentiment remained subdued, with 28 constituents declining and 22 advancing, indicating a cautious tone among investors. Most of the other indices ended in red. Midcap and Smallcap indices were marginally down. Sectorally too, apart from FMCG and Oil & Gas, others witnessed weak performance. Technically, Nifty 50 started the week on an uncertain note as investors searched for a fresh set of triggers. 20D EMA continues to offer support and RSI is supportive of bullish momentum. Near term support and resistance are at 25,180/25,000 and 25,600/25,740. On shares to buy on Tuesday, Sachin Gupta recommends two stocks on Tuesday — Balrampur Chini Mills Ltd, and Metropolis Healthcare Ltd. On the daily scale, the stock is displaying a strong bullish setup, having recently confirmed an Inverse Head & Shoulders pattern breakout, which is a classic reversal signal indicating potential upside. Following the breakout, the stock is consolidating around the neckline, suggesting strength and a healthy base formation before the next leg higher. Additionally, the stock is trading above its 21-day EMA, reflecting short-term momentum in favour of the bulls. A positive crossover in the MACD further reinforces the bullish bias, while rising volume during the breakout and consolidation phase adds credibility to the uptrend, signaling increasing investor interest and potential for continued upward movement. Hence, traders are advised to hold their existing positions, with short-term support placed at 570 levels and immediate resistance seen near 630 levels. A decisive move above this resistance could open the door for further gains. On the daily timeframe, the stock has given a consolidation breakout, accompanied by a positive moving average crossover between the 50-day and 100-day EMAs, signaling a strengthening trend. This breakout is supported by a surge in volume and bullish price action, confirming strong buying interest. Additionally, a positive crossover in the RSI further reinforces the bullish momentum. On the weekly chart, the stock has managed to move above the 50% Fibonacci retracement level, indicating a recovery of prior losses and the potential for a sustained uptrend. These combined signals suggest strong upside potential in the near term. Traders are advised to maintain their holding positions and also consider fresh buying around 1,820, with upside targets of 1,945 and 2,040, while maintaining a strict stop loss at 1,700 on a closing basis. Disclaimer: The views and recommendations above are those of individual analysts, experts and broking companies, not of Mint. We advise investors to check with certified experts before making any investment decision.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Nectar Lifesciences hits 52-week low; why are investors dumping stock?
Nectar Lifesciences share price hit a 52-week low at ₹18.6 per share, slipping 19.6 per cent in trade. At 10 AM, Nectar Lifesciences shares were trading 16.62 per cent lower at ₹19.31 per share on the BSE. In comparison, the BSE Sensex was up 0.04 per cent at 83,478.31. The selling pressure came after the company's move to sell off its core business division to Ceph Lifesciences Private Limited disappointed investors. In the exchange filing the company said that it has inked a definitive Business Transfer Agreement (BTA) for the sale of its core business division—comprising the manufacture, distribution, and marketing of active pharmaceutical ingredients (APIs) and formulations—to Ceph Lifesciences Private Limited, for a consideration of ₹1,270 crore, on a slump sale basis. Additionally, the company has entered into an Asset Purchase Agreement (APA) for the sale of its menthol business assets to Ceph Lifesciences for ₹20 crore, marking a comprehensive restructuring move aligned with its future strategy. "By divesting mature segments of our business, we are laying the foundation for a focused and agile organisation geared towards innovation and long-term value creation," Nectar Lifesciences Promoter and Chairman Sanjiv Goyal said. The proceeds from the sale will be used to: repay existing debt, invest in new and emerging business areas, reward shareholders, subject to applicable approvals, and fund future corporate and growth initiatives. The transaction was approved by the company's board on July 7, 2025, and is subject to shareholder approval at the Extraordinary General Meeting (EGM) to be held on August 4, 2025. The transaction is expected to be completed on or before September 20, 2025, and there will be no change in the company's existing shareholding. ALSO READ | About Nectar Lifesciences Limited Nectar Lifesciences Ltd. is an established pharmaceutical company focused on research-driven innovation, manufacturing, and global distribution. The company is listed on the NSE and BSE and is committed to enhancing stakeholder value through disciplined strategy and operational excellence.
Time of India
an hour ago
- Time of India
Stock market update: Nifty Bank index advances 0.32% in a weak market
NEW DELHI: The Nifty Bank index traded positive around 10:09AM(IST)on Tuesday in a weak market. Kotak Mahindra Bank Ltd.(up 3.69 per cent), IndusInd Bank Ltd.(up 0.56 per cent) and ICICI Bank Ltd.(up 0.35 per cent) were among the top gainers. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Cara Membantu Orang Terkasih Menghadapi Limfoma Limfoma Pelajari Undo Canara Bank(down 0.63 per cent), Bank of Baroda(down 0.54 per cent), Federal Bank Ltd.(down 0.38 per cent), Axis Bank Ltd.(down 0.35 per cent) and Au Small Finance Bank Ltd.(down 0.32 per cent) were the top losers on the index. The Nifty Bank index was up 0.32 per cent at 57132.05 at the time of writing this report. Benchmark NSE Nifty50 index was down 9.25 points at 25452.05, while the BSE Sensex was down 5.19 points at 83437.31. Live Events Among the 50 stocks in the Nifty index, 20 were trading in the green, while 30 were in the red. Shares of JP Power , RattanIndia Power , Vodafone Idea , PC Jeweller and Alok Industries were among the most traded shares on the NSE. Shares of California Soft , Reliance Naval & Engg, Sumeet Ind , Kavveri Telecom and TN Telecom hit their fresh 52-week highs in today's trade, while Nectar Lifesc, Sadhana Nitro, Dreamfolks Services, Globe Civil Projects and Visa Steel Ltd hit fresh 52-week lows in trade.
